Literature DB >> 2570876

Positive inotropic effect of somatostatin in guinea-pig ventricular muscles.

S Hirai1, J Hasegawa, H Mashiba.   

Abstract

We investigated the effect of somatostatin (SS) in guinea-pig ventricular muscles using a force transducer and a conventional microelectrode method. Instead of a negative inotropic effect in atrial muscles, SS (10(-11) to 10(-7) M) elicited a positive inotropic effect in ventricular muscles in a concentration-dependent fashion, without changing the time course of contraction. The positive inotropic effect of SS was accompanied by a significant enhancement of the slow action potentials and was suppressed by diltiazem and phentolamine. An increase of extracellular Ca2+ concentration or stimulation frequency enhanced the positive inotropic effect of SS. The positive inotropic effect of SS was not suppressed in the presence of propranolol, metoclopramide, cimetidine or indomethacin, and it appeared even under cold conditions. These results suggest that SS has a positive inotropic effect in guinea-pig ventricular muscle, which is at least partly due to an increase in the slow inward Ca2+ current.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570876     DOI: 10.1016/0022-2828(89)90826-2

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

Review 1.  The role of neuropeptides in adverse myocardial remodeling and heart failure.

Authors:  Alexander Widiapradja; Prasad Chunduri; Scott P Levick
Journal:  Cell Mol Life Sci       Date:  2017-01-17       Impact factor: 9.261

2.  Effect of urapidil on the action potentials in the guinea-pig ventricular myocardium.

Authors:  N Noguchi; J Hasegawa; H Omodani; T Nawada; S Matsuoka; I Hisatome; H Kotake; H Mashiba
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

3.  Short-term effects of somatostatin analogue (SMS 201-995) on left ventricular function in healthy persons: a scintigraphic study.

Authors:  T Erbas; A Usman; B Erbas; E Varoglu; T Aras; C Bekdik
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

4.  The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly.

Authors:  Laura De Marinis; Antonio Bianchi; Gherardo Mazziotti; Marco Mettimano; Domenico Milardi; Alessandra Fusco; Vincenzo Cimino; Giulio Maira; Alfredo Pontecorvi; Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Neuronostatin inhibits cardiac contractile function via a protein kinase A- and JNK-dependent mechanism in murine hearts.

Authors:  Yinan Hua; Heng Ma; Willis K Samson; Jun Ren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-24       Impact factor: 3.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.